加载中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新数据
US$3.63
−US$0.39 · -9.70%
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.
收盘时
US$3.63
−US$0.39 · -9.70%
盘后
US$3.70
+US$0.07 · +1.93%
10月12日 19:30 ET
盘中时间采用ET。市场数据可能有所延迟。
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.
日内区间
当前US$3.63
52周区间
当前US$3.63
盘中时间采用ET。市场数据可能有所延迟。
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.
日内区间
当前US$3.63
52周区间
当前US$3.63
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（CAD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 42.69万 CAD | 38.99万 CAD | 18.11万 CAD | 8.07万 CAD | — |
| 销货成本 | 250.35万 CAD | 11.89万 CAD | 33.81万 CAD | 2.68万 CAD | — |
| 毛利 | −207.66万 CAD | 27.09万 CAD | −15.7万 CAD | 5.39万 CAD | — |
| 研究与开发 | 34.82万 CAD | 14.45万 CAD | 15.21万 CAD | 13.32万 CAD | 24.09万 CAD |
| 销售、一般及管理费用 | 272.13万 CAD | 399.21万 CAD | 393.35万 CAD | 613.99万 CAD | 506.21万 CAD |
| 营业费用 | 245.84万 CAD | 588.01万 CAD | 422.36万 CAD | 744.37万 CAD | 605.54万 CAD |
| 利息收入 | 1.43万 CAD | 2665 CAD | 13.64万 CAD | 6.69万 CAD | 5.5万 CAD |
| 利息支出 | 53.24万 CAD | 42.93万 CAD | 4.37万 CAD | 2.8万 CAD | 1.92万 CAD |
| 折旧和摊销 | 95.03万 CAD | 86.79万 CAD | 72.96万 CAD | 29.36万 CAD | 4.71万 CAD |
| 营业利润 | −453.5万 CAD | −560.92万 CAD | −438.06万 CAD | −738.98万 CAD | −605.54万 CAD |
| 净利润 | −371.73万 CAD | −603.59万 CAD | −519.45万 CAD | −735.08万 CAD | −601.95万 CAD |
公司数据更新于 2026年10月13日。
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
